InvestorsHub Logo
Followers 87
Posts 6685
Boards Moderated 1
Alias Born 09/18/2009

Re: None

Monday, 03/13/2023 11:31:13 AM

Monday, March 13, 2023 11:31:13 AM

Post# of 42881
I wonder if we're going to see a 10-K, or an NT 10-K, as we await the Final Report of the ACTIV-5 trial. I suspect that Report, coupled with our study which demonstrated a sustained reduction in cytokine levels, may be sufficiently indicative of the positive safety and efficacy performance of lenz to warrant the resubmission of our EUA application.